Juvenile Idiopathic Arthritis — Trials, FDA Actions & Pivotal Research

20 active Juvenile Idiopathic Arthritis trials currently recruiting in the US, sourced from ClinicalTrials.gov.

Synced daily from openFDA and ClinicalTrials.gov. Last sync: August 27, 2026.

Active Juvenile Idiopathic Arthritis trials

Currently recruiting US trials matching Juvenile Idiopathic Arthritis, sourced live from ClinicalTrials.gov. We’ll add per-event articles here as those trials post results or hit primary completion.

Pain-Sleep in Rheumatic Disease

for Rheumatic Diseases

Sponsor: The Hospital for Sick Children

Sex: Female·Age: 12 - 18

Code: NCT07775612·Not Yet Recruiting·Listed Aug 20, 2026

Validity and Reliability of the International Physical Fitness Questionnaire and the Self-Perceived Health-Related Physical Fitness Questionnaire in Children and Adolescents With JIA and FMF

for Juvenile Idiopathic Arthritis

Sponsor: Istanbul University - Cerrahpasa

Sex: All·Age: 10 - 18

Code: NCT07617558·Not Yet Recruiting·Listed Jun 2026

Sarcopenia and Juvenile Idiopathic Arthritis

for Juvenile Idiopathic Arthritis

Sponsor: CHU de Reims

Sex: All·Age: 15 - 40

Code: NCT07634354·Not Yet Recruiting·Listed Jun 2026

Tenosynovitis in Polyarticular and Oligoarticular Juvenile Idiopathic Arthritis

for Juvenile Idiopathic Arthritis

Sponsor: Assiut University

Sex: All·Age: Up to 16

Code: NCT07553910·Not Yet Recruiting·Listed Apr 2026

A Study on the Use of Canakinumab Among Familial Mediterranean Fever and Still's Disease Patients

for Familial Mediterranean Fever

Sponsor: Novartis Pharmaceuticals

Sex: All·Age: 1+

Code: NCT07517250·Recruiting·Listed Apr 2026

Apply to this trial

Methotrexate Alone vs Methotrexate + Etanercept for Minimal/Low Disease Activity in Juvenile Idiopathic Arthritis

for Juvenile Idiopathic Arthritis

Sponsor: University of Child Health Sciences and Children's Hospital, Lahore

Sex: All·Age: 2 - 16·Accepts healthy volunteers

Code: NCT07386587·Phase 3·Enrolling By Invitation·Listed Feb 2026

Regulatory Post-Marketing Surveillance in Hidradenitis Suppurativa, Pediatric Plaque Psoriasis and JIA Treated With Cosentyx®(Secukinumab) in Korea

for Hidradenitis Suppurativa

Sponsor: Novartis Pharmaceuticals

Sex: All·Age: 6 - 100

Code: NCT07243782·Recruiting·Listed Nov 2025

Apply to this trial

Pain in Juvenile Arthritis

for Juvenile Idiopathic Arthritis

1 location in St Louis

Sponsor: Washington University School of Medicine

Sex: All·Age: 9 - 17·Accepts healthy volunteers

Code: NCT07217782·Recruiting·Listed Oct 2025

Apply to this trial

Clinical Study of BCMA/CD70-targeted CAR-T Therapy for Refractory Pediatric Rheumatic Diseases

for Juvenile Dermatomyositis (JDM)

Sponsor: Chongqing Precision Biotech Co., Ltd

Sex: All·Age: 5+

Code: NCT07184450·Phase 1·Recruiting·Listed Sep 2025

Apply to this trial

Assessment of Composite Inflammatory Ratios in Juvenile Idiopathic Arthritis and Their Association With Disease Activity

for Juvenile Idiopathic Arthritis

Sponsor: Sohag University

Sex: All·Age: Up to 16·Accepts healthy volunteers

Code: NCT07083466·Not Yet Recruiting·Listed Jul 2025

Feasibility of a Diet Intervention for Juvenile Arthritis

for Arthritis, Juvenile

Sponsor: The Hospital for Sick Children

Sex: All·Age: 8 - 18

Code: NCT06474546·Recruiting·Listed Jun 2024

Apply to this trial

Dynamic Gait Index as a Functional Gait Assessment Measure in Children With JIA

for Juvenile Idiopathic Arthritis

Sponsor: Istanbul University - Cerrahpasa

Sex: All·Age: 8 - 16·Accepts healthy volunteers

Code: NCT06870045·Recruiting·Listed Mar 2025

Apply to this trial

Mesenchymal Stem Cells Infusion in Patients With Autoimmune Diseases

for Rheumatoid Arthritis

Sponsor: National Institute of Blood and Marrow Transplant (NIBMT), Pakistan

Sex: All·Age: 18 - 50

Code: NCT06888973·Phase 1, Phase 2·Enrolling By Invitation·Listed Mar 2025

Optimizing Treatment for Patients With Juvenile Idiopathic Arthritis in Sustained Remission: The MOVE-JIA Trial

for Juvenile Idiopathic Arthritis

Sponsor: Oslo University Hospital

Sex: All·Age: 2 - 17

Code: NCT06653634·Phase 4·Recruiting·Listed Oct 2024

Apply to this trial

M3-JIA: Making Mindfulness Matter for Children With JIA

for Juvenile Idiopathic Arthritis

Sponsor: London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's

Sex: All·Age: 4 - 12

Code: NCT06376149·Recruiting·Listed Apr 2024

Apply to this trial

Analysis of Peripheral Blood Lymphocytes in Patients With Juvenile Idiopathic Arthritis With Respect to Disease Subtypes and Therapy

for Juvenile Idiopathic Arthritis

Sponsor: Sohag University

Sex: All·Age: 6 Months - 16·Accepts healthy volunteers

Code: NCT06413563·Not Yet Recruiting·Listed May 2024

Imaging Based Uveitis Screening for Children With Juvenile Idiopathic Arthritis

for Uveitis, Anterior

Sponsor: Institute of Child Health

Sex: All·Age: 2 - 12

Code: NCT05984758·Not Yet Recruiting·Listed Aug 2023

Korea Xeljanz Post-marketing Surveillance for Juvenile Idiopathic Arthritis

for Psoriatic Arthritis, Juvenile

Sponsor: Pfizer

Sex: All·Age: 2 - 17

Code: NCT05754710·Recruiting·Listed Mar 2023

Apply to this trial

Virtual Self-Management Program for JIA

for Juvenile Idiopathic Arthritis

Sponsor: University of Calgary

Sex: All·Age: 12 - 17

Code: NCT06184100·Recruiting·Listed Dec 2023

Apply to this trial

Study of Oral Upadacitinib and Subcutaneous/Intravenous Tocilizumab to Evaluate Change in Disease Activity, Adverse Events and How Drug Moves Through the Body of Pediatric and Adolescent Participants With Active Systemic Juvenile Idiopathic Arthritis.

for Juvenile Idiopathic Arthritis

5 locations incl. Phoenix

Sponsor: AbbVie

Sex: All·Age: 1 - 17

Code: NCT05609630·Phase 3·Recruiting·Listed Nov 2022

Apply to this trial